Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial.

Deidre J SmithJerome SarrisNathan L DowlingManjula O'ConnorChee H Ng

Published in: Nutritional neuroscience (2017)

Within the major limits of this open-label pilot study, the results suggest that DHA may provide additional adjunctive benefits in patients with mild- to -moderate depression.

Keyphrases

low dose
fatty acid
open label
clinical trial
depressive symptoms
high dose
phase ii
phase iii
phase ii study
study protocol
randomized controlled trial
squamous cell carcinoma
rectal cancer
placebo controlled